Craig Eagle - 07 Nov 2022 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
CHIEF MEDICAL OFFICER
Signature
/s/ John Saia, as attorney-in-fact for Craig Eagle
Issuer symbol
GH
Transactions as of
07 Nov 2022
Transactions value $
$0
Form type
4
Date filed
09 Nov 2022, 16:32
Previous filing
08 Sep 2022
Next filing
16 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH STOCK OPTION (RIGHT TO BUY) Award $0 +54.9K $0.00 54.9K 07 Nov 2022 COMMON STOCK 54.9K $47.20 Direct F1
transaction GH RESTRICTED STOCK UNITS Award $0 +27.4K $0.00 27.4K 07 Nov 2022 COMMON STOCK 27.4K $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This represents a stock option granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter.
F2 This represents a restricted stock unit award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on November 7, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter.
F3 Not applicable to Restricted Stock Units.